2022
DOI: 10.1007/7854_2022_372
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 82 publications
0
1
0
Order By: Relevance
“…In particular, as an inhibitory heteroreceptor, H 3 R can affect the level of some neurotransmitters, such as serotonin, norepinephrine, γ-aminobutyric acid, and glutamate in the CNS related to epilepsy [7][8][9]. It has been proved that H 3 R antagonists can treat epilepsy by promoting the synthesis and secretion of histamine [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, as an inhibitory heteroreceptor, H 3 R can affect the level of some neurotransmitters, such as serotonin, norepinephrine, γ-aminobutyric acid, and glutamate in the CNS related to epilepsy [7][8][9]. It has been proved that H 3 R antagonists can treat epilepsy by promoting the synthesis and secretion of histamine [10][11][12].…”
Section: Introductionmentioning
confidence: 99%